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Normal human melanocytes and melanoma cells have been 
reported to produce several cytokines. Previously we demon-
strated that neonatal human melanocyte proliferation and 
tyrosinase activity are inhibited by interleukin-la, tumor 
necrosis factor-a, and interleukin-6. We have now also 
shown that interleukin- lp induces an inhibiting effect on 
neonatal melanocyte tyrosinase activity with little effect on 
melanocyte proliferation. We investigated the ability of neo-
natal and adult human melanocytes to synthesize interleu-
kin-la and p. By immunocytochemistry, using monoclonal 
antibodies against interleukin-la and p, we observed that 
ithin the epidermis, keratinocytes constituti-
vely produce interleukin (IL)-l and can be 
stimulated to synthesize several other cyto-
kines including IL-6, IL-8, colony-stimulat-
ing factors, and tumor necrosis factor-a 
(TNF-a) in vi.tro [1- 5]. Other epidermal factors th.at p~rticipate in 
the immune/1l1f1ammatory response are the arachldol1lc aCid me-
tabolites of the lipoxygenase and cyclooxygenase pathways, some of 
which possess chemotactic activity (6). These cytokines and inflam-
matory mediators govern the homeostasis of the epidermis and are 
al tered during disease states, which can affect epidermal cell func-
tion. 
The role of the melanocyte in the scheme of cutaneous inflam-
mation and immunity is not well understood. Human melanoma 
ce lls have been reported to produce several cytokines including IL-l 
and IL-6 [7,8). Preliminary reports suggest that normal human mel-
anocytes may also synthesize these and other inflammatory media-
tors including IL-8:~§ (9). Previously we have shown that neonatal 
melanocytes synthesize specific Iipoxygenase metabolites, namely, 
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This study was previously reported in abstract form (Swope VB, Abdel-
Malek ZA, Babcock GF, Skramkoski RM, Nordlund JJ: Adult and neonatal 
human melanocytes are regulated by epidermal cytokines and synthesize 
interleukin-1a and fJ (abstr). J I"vest Dermatof 96:549, 1991). 
:j: Kbck A, Schauer E, Luger TA: The human melanocyte is an immuno-
competent epidermal cell: production of immunomodulating cytokines 
(abstr). Arch Dermato f Res 283:56, 1991. 
§ Mizutani H, Miwa N, Mizutani T , Kupper TS: Melanocytes produce 
IL-l beta and contain an IL-1 beta convertase activity: a potential in vivo 
mechanism for paracrine conversion of keratinocyte pro-IL-1 beta (abstr). 
] Irl ves! Dermatof 94:556, 1990. 
neonatal and adult melanocytes stain positively for both cy-
tokines. Flow-cytometric analysis revealed that the percent-
age of melanocytes positive for interleukin-la was always 
greater than that for interleukin-lp. The ability of neonatal 
and adul t melanocytes to synthesize interleukin-1 a and p was 
further confirmed using the polymerase chain reaction. 
These results clearly indicate that human melanocytes syn-
thesize interleukin-la and p, and that these cytokines may 
function as autocrine and/or paracrine regulators of cells in 
the epidermis. ] Invest Dermato! 102:749-753, 1994 
leukotriene B4 and 12-HETE.~ Additionally, Yohn et al demon-
strated that normal human melanocytes can be induced by cytokines 
to express intercellular adhesion molecule-l (ICAM-l) [10). 
The location of melanocytes along the basement membrane and 
their ability to synthesize inflammatory mediators and to express 
ICAM-l suggest an important role for these cells in leukocyte traf-
ficking and cutaneous inflammation. 
~ot only does. the melanocyte appear to have the capacity to 
partICipate m the mflammatory process, but in turn the mediators of 
inflammation and immunity can affect melanocyte function . Clini-
cally, post-inflammatory hyper- and hypopigmentation have been 
described (11). Cutaneous inflammation following ultraviolet B 
irradiation-induced sunburn or severe tissue damage of a thermal 
burn can result in varying degrees of hyper pigmentation. Less com-
~10nly, hypop.igmentation has been described as in the depigment-
mg disease VitIligo. We have previously reported that human mela-
nocyte proliferation and melanogenesis are inhibited by IL-la, 
IL-6, and TNF-a ill vitro (12). The goal of our studies presented here 
was to determine whether normal human melanocytes have the 
ability to synthesize interleukin-la and p. This capability to pro-
duce IL-l wou ld suggest a potential role for melanocytes:is regula-
tors of epidermal cell function via an autocrine or paracrine manner. 
MATERIALS AND METHODS 
Materials MCDB 153 medium, 0.25% trypsin, penicillin-streptomycin 
solutIOn, cholera toxin, 3-isobutyl-1-methylxanthine, human recombinant 
basic fibroblast growth factor, human transferrin, a-tocopherol, insulin 
(from bovine pancreas) , fetal bovinc serum, ncwborn calf serum, bovine 
serum albumin (BSA; Fraction V), biotinylatcd a:lti-human ICAM-1 anti-
body (murine IgG,), and normal goat serum were obtained from Sigma 
Chemical Company (St. Louis, MO). Human recombinant IL-1fJ was pur-
'Il Abdel-Malek Z, Swope V, Doupnik C, LeikaufG, Nordlund] : Respon-
siveness of malignant and normal melanocytes to autocrine eicosanoids 
(ahstr). J Illvest Dermatof 92:393A, 1989. 
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chased from Genzyme Corp. (Cambridge, MA). Monoclonal antibodies 
(murine IgG,) to human interleukin-la andpwere a generous gift from the 
Immunex Corporation (Seattle, W A) . Affinity-purified goat anti-mouse 
IgG-f1uorescein isothiocyanate (FITC) was obtained from Cappel-Division 
of Organon Teknika Corporation (West Chester, PAl. Monoclonal anti-
herpes simplex I (murine IgG,) was obtained from Chemicon International, 
Inc. (Temecula, CAl. Becton-Dickinson Immunocytochemistry Systems 
(Mountainview, CAl supplied the mouse monoclonal IgG, irrelevant anti-
body control directed against keyhole limpet hemocyanin, an antigen not 
expressed by human cells. Bovine pituitary extract was purchased from 
Clonetics (San Diego, CAl. The D-biotinyl-E-amidocaproic acid N-
hydroxy succinimide ester and streptavidin-sulforhodamine 101 were ob-
tained from Boehringer-Mannheim (Indianapolis, IN). Human IL-la and 
IL-1P primers were obtained from Clontech Laboratories (Palo Alto, CAl. 
Culture Conditions Normal human melanocytes were derived from ei-
ther neonatal foreskins, or adult breast skin following cosmetic surgery. The 
skin samples were processed as described previously [12). The growth me-
dium for neonatal foreskin-derived melanocytes consisted of MCDB 153 
medium, 1.25% heat-inactivated fetal bovine serum, 1.25% newborn calf 
serum, 10-4 M 3-isobutyl-l -methylxanthine, 5 ~g/ml insulin, 2 ~g/ml 
a-tocopherol, 2 ~g/ml transferrin, 20 ng/ml cholera toxin, 1.2 ng/ml 
human recombinant basic fibroblast growth factor (bFGF), and 1 % penicil-
lin-streptomycin (10,000 U/ml and 10,000 ~g/ml, respectively). Adult 
human melanocytes were cultured as described by Medrano and Nordlund 
[13) using the following medium: MCDB 153 medium, 5% heat-inacti-
vated fetal bovine serum, 0.2% bovine pituitary extract,S ng/ml 12-0-
tetradecanoyl-phorbol 13-acetate, 5 ~g/ml insulin, 1 ~g/ml transferrin, 
1 ~g/ml a-tocopherol, 0.6 ng/ml human recombinant basic fibroblast 
growth factor, and 1 % penicillin-streptomycin. The cells were maintained 
in a humidified incubator with 5% CO2 at 37'C. 
Determination of Tyrosinase Activity Melanocyte cultures were har-
vested using an ethylenediamine tetraacetic acid containing Tyrode's solu-
tion followed with a brief exposure to a 0.25% trypsin solution. The mela-
nocytes were seeded into 2-cm2 culture wells at 0.03 X 106 cells/wel l. Mel-
anocytes were treated with human recombinant IL-1P for a total of 7 d, and 
3H-tyrosine (1 ~Ci/ml) was added during the last 24 h of the experiment. 
The conditioned medium from each well was saved to determine tyrosinase 
activity, and the final cell number was determined. The tyrosine hydroxylase 
activity of tyrosinase was measured ill sitll according to a modification of the 
Pomerantz charcoal absorption method as described previously (12). This 
assay is based on measuring the amount of 3H20 released as 3H-tyrosine is 
converted to L-DOPA by tyrosinase. 
Immunocytochemical Analysis of Interleukin-ta and P Melano-
cytes were seeded onto eight-well Lab Tek chamber sl ides (Baxter Scientific 
Products, Obetz, .OH) at a density of 10,000 cells per well. After 48 h of 
incubation, the melanocytes were fixed in a 4% paraformaldehyde/0.05% 
glutaraldehyde solution followed by permeabilization with 0.2% triton 
X-I00. The cells were washed three times with 0.5 mg/ml sodium borohy-
dride to block free reactive aldehyde groups. Melanocytes were then incu-
bated in phosphate-buffered saline containing 3% bovine serum albumin, 
2% normal goat serum, and 0.05% sodium azide for 45 min to block nonspe-
cific binding sites. Then the cells were incubated for 1 h with either the 
monoclonal biotinylated anti-IL-1P (67 ~g/ml), monoclonal anti- IL-la 
(80 ~g/ml), or negative isotype controls described below. The antibody 
directed against IL-1P was biotinylated to increase the sensitivity of this 
staining method. Either the streptavidin-sulforhodamine 101 or goat anti-
mouse IgG-FiTC secondary reagent was added to the appropriate well and 
incubated for 30 min. This procedure was performed at room temperature 
and multiple washing ~tep.s were carried out between each step of the stain-
ing procedure . NegatIve ISO type control groups conSIsted of melanocytes 
stained with either a biotinylated murine IgG , monoclona.l anti-ICAM-l 
antibody (which was negative for melanocytes by immunocytochemical 
staining of cultured cel ls and immunohistochemical staining of skin sec-
tions) or a monoclonal murine IgG t irrelevant antibody as described in the 
materials section. The concentrations of the irrelevant antibodies were 
equivalent to those used for either the biotinylated anti-IL- tp or anti-IL-
la antibodies. A negative control lacking the primary antibody was also 
included to identify non-specific staining due to the secondary antibody 
alone. 
Flow-Cytometric Detection of Interleukin-la and P The'single 
color stai ning Plethod was performed in the following manner. Melanocytes 
in single cel l suspension were fixed in a 4% paraformaldehyde/0.05% glu-
taraldehyde solution and permeabilized in 0.2% Triton X-IOO. The cells 
were incubated with one of the following monoclonal antibodies: anti - IL-
Ia, anti - IL-lP, or anti- herpes simplex I (lgG t isotype control) for 30 min. 
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The concentration of these antibodies found to be optimum using this stain-
ing method was 3.0 ttg/ml. The cel ls were incubated with the goat anti-
mouse IgG-FITC secondary antibody for 30 min. Repeated washes were 
carried out between each staining step and the cells were stored in 2% 
paraformaldehyde until analysis. A negative control lacking the primary 
antibody was also included to identify non-specific staining due to the sec-
ondary antibody alone. This negative control lacking the primary antibody 
did not differ from unstained cells when analyzed by flow cytometry . 
Flow Cytometry and Data Analysis The prepared specimens were ana-
lyzed with anEPICS 753 (Coulter Cytometry, Hialeah, FL) equipped with a 
Bio-Sense tip, a front argon ion laser adjusted to emit at 488 Ill) (300 m W), 
and a second argon ion laser configured to excite the dye rhodamine 590 
chloride (R6G). Forward and orthogonal angle light scatter were measured 
from the 488-nm laser light. FITC was measured through a 530-nm band-
pass. Histograms and scatter grams were set to collect 10,000 gated events on 
a linear scale. Single parameter analysis was performed using the IMMUNO 
program in the off-line EASY2 software package (Coulter Cytometry, Hia-
leah, FL). This program subtracts the negative control from the test samples 
giving an estimate of the percentage of cells that are positive above back-
ground fluorescence. 
Polymerase Chain Reaction Amplification of Interleukin-ta and P 
Total cel lular RNA was obtained by resuspending melanocytes in guanidine 
thiocyanate, and was stored at -70'C until analysis. Due to the low IL-l 
mRNA expression that could be detected by Northern blot analys is, poly-
merase chain reaction (PCR) was employed to amplify the IL-l signal. The 
PCR technique has been previously described in detail [1 4]. The PCR ana.ly-
sis was performed using primers for IL-la and IL-lP along with a primer for 
p-actin, the internal standard. Aliquots of the reaction mixture were run on a 
minigel and autoradiographic techniques employed to determine the final 
results. The IL-l signals were quantitated by scanning the autoradiogram 
using an LKB Ultrascan XL laser densitometer. The PCR primers were 
commercially obtained from Clonetech Laboratories (Palo Alto, CAl. As 
tested by the manufacturing laboratory, the IL-l a and p primers did not 
cross react with each other. We have confirmed this independently by 
testing these primers on the COLO keratinocyte cell line. The cDNA 
positive controls for IL-la and p were provided by Clonetech Laboratories. 
RESULTS 
As previously reported, we found that human recombinant IL-la 
inhibited human melanocyte proliferation and melanization. We 
wanted to extend these studies to include IL-1P so that we could 
identify the effecti veness of IL-lp on melanocyte function. N eona-
tal melanocytes were cultured in the presence of human recombi-
nant IL-1P for 7 d (Table I). IL-1P significantly inhibited tyrosinase 
activity at concentrations of 50 and 100 U / ml (25 U / ml is equal to 
2.9 X 10-12 M) and had no significant effect on cellular prolifera-
tion. Thus, both IL-la and P may act to regulate melanocyte func-
tion. 
N eonatal melanocytes were stained using immunocytochemistry 
for IL-la and IL-lP as described in Materials alld Methods. The mela-
nocytes stained w ith the monoclonal anti - IL-la antibody and the 
goat anti-mouse IgG-FITC secondary antibody were significantly 
brighter when compared to the melanocytes that were stained with 
the negative isotype control (Fig lA/B) . The monoclonal antibody 
against IL-lp was biotinylated to enhance the detection of this cyto-
kine. When neonatal melanocytes were incubated with the biotiny-
lated anti - IL-lp followed .by the streptavidin-sulforhodamine sec-
ondary antibody, significant IL-lP staining was observed. Biotiny-
lated anti-human ICAM-l was included as a negative isotype con-
trol. A predominant cytoplasmic staining pattern was observed for 
IL-la and IL-lP in the melanocytes. Adult human melanocytes 
were immunocytochemically stained with antibodies against IL-la 
and P with similar positive results as described for neonatalmelano-
cytes (data not show n) . 
Human melanocytes were analyzed using flow cytometry to de-
tect the synthesis of IL-la and p. This method was chosen to quan-
titate the number of IL-l- positive melanocytes within a popula-
tion. Initially, we attempted to stain intact unpermeabilized neona-
tal melanocytes with the antibodies directed against IL-la and p. 
This was unsuccessful, suggesting that there is undetectable mem-
brane bound IL-l. After permeabilizing the cellular membrane with 
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Table I. Effects of IL-1P on Neonatal Melanocyte Proliferation and Tyrosinase Activity" 
Cellular Proliferation Tyrosinase Activity 
10-5 X Cells per Well 
Mean ± SO 
Mean Percent of 
Control ± SO 
OPM per 106 Cells 
Mean ± SO 
Mean Percent of 
Control ± SO 
Untreated control 
IL-l/1 25 V/ml 
IL-l/1 50 V/ml 
IL-1P 100 V/ml 
1.61 ± 0.16 
1.32 ± 0.02 
1.80 ± 0.18 
1.87 ± 0.07 
100 ± 10 
82 ± 1 
112 ± 11 
116 ± 4 
687,580 ± 65,860 
68 1,650 ± 43,350 
496,950 ± 40,340 
440,700 ± 6,620 
100 ± 10 
99 ± 6 
72± 6b 
64 ± lb 
• Neonatal human melanocytes were seeded at a density of 0.03 X 10· cells/well in a 6-wcll cluster plate and were treated the following day and every other day thereafter with 25, 
50, or 100 U /ml IL-1P (25 U /ml = 2.9 X 10-12 M) for a total of7 d. This is a representative experimentthat describessimibr results found in four different neonata l melanocyte cell 
strains . 
• Values arc statistically different from untreated control at p < 0.05 as evaluated by Student t test. 
Triton-X 100, significant staining was observed for both IL-la and 
p. Indirect immunofluorescence staining of both neonatal and adult 
melanocytes consistently demonstrated a greater percentage of cells 
positive for IL- la than IL-Ip. As shown in Fig 2, the background 
fluorescence is represented by the shaded area and the fluorescence 
of the test population is positive when greater than the background 
(the unshaded area) . Figure 2 represents neonatal melanocytes that 
stained positively for IL-la (61.82%) and IL-l,B (36.98%). The 
negative isotype control included here was a monoclonal anti-
A 
c 
Herpes Simplex I (IgG 1) antibody that demonstrated 8.46% non-
specific staining (Fig 2). 
To conclusively demonstrate the ability of human melanocytes to 
synthesize both IL-la and p, we investigated the specific gene tran-
scription of these two cytokines in neonatal and adult melanocytes. 
The peR was used to enhance the reverse-transcribed IL-l mRNA, 
because the mRNA was barely detectable by Northern blot analysis 
(data not shown). After 27 peR cycles for IL-la and 18 peR cycles 
for IL-lP, very strong DNA bands were detected in both the neona-
B 
D 
Figure 1. Immunocytochemical detection of IL-l in human melanocytes. Neonatal melanocytes were incubated with the monoclonal anti-IL-la or 
anti - IL-l/1 antibody as described in Materials atld Methods . A and B represent the fluorescence microscopy of neonatalmelanocytes stained with the IgG, isotype 
control and anti-IL-la, respectively. C and D represent the fluorescence microscopy of neonatalmelanocytes stained with the biotinylated IgG, isotype 
control and the biotinylated anti- IL-l/1, respectively. Bar, 50 tJ.m. Adult human melanocytes also stained positively for both IL-la and IL-1/1 (data not shown) . 
752 SWOPE ET AL 
A 6 
B 
c 
Fr e q J\ 
XIO 
10 
r ... rc e nf "U S I t i ,.H~ S : 
~ed" c ~d CI,i - Square: 
HI01 22 4B 
ANTI - Il. - IA 
Percellt I'o s itiy(' s : 
Reduced C hl - S~uarc: 
NIIH ZZ '18 
AHT1 - IL - IB 
61.6 2 
2 .~CJ 
J6 . 'J9 
2. 5:; 
P("rc('nt Po si tive s : 0.46 
Reduced Chi - Squar ... : L.S Z 
HIIH224D 
H ERPES 
15 20 2 5 30 
Figure 2. Detection of IL-lcx and IL-1P positive melanocytes by flow-cy-
tomctric analysis. Neonatal melanocytcs were incubated with either the 
anti - IL-lcx. anti- IL-1P. or anti-Herpes Simplex I plus the anti-mouse 
IgG-FITC secondary antibody and analyzed by flow cytometry. A repre-
sents the IL-lcx staining. B the IL-1P staining. and C the negative IgG, 
isotype control. anti-Herpes Simplex I. UtlsiJaded area, cells positive for 
either IL-lcx. P. or the isotype control; shaded area, negative control popula-
tion incubated with the secondary antibody only. Both neonatal and adult 
melanocytes (data not shown) consistently demonstrated a greater percent-
age of cel ls positive for IL-lcx than IL-lp. 
tal and adult melanocytes. indicating the expression of the IL-1a 
and {l genes in human melanocytes from different age groups (Fig 
3). The IL-1a and {l positive controls for this study were provided 
by the manufacturer. 
DISCUSSION 
Interleukin-l is a primary cytokine responsible for initiating epider-
mal inflammation and immunity [5]. Interleukin-l also has pro-
found paracrine and autocrine effects on epidermal cells. Keratino-
cytes respond to IL-1 with increased proliferation. whereas 
melanocytes respond to IL-1a with decreased proliferation and 
melanogenesis [1- 5.12]. We have also shown here that IL-1{l in-
hibits neonatal melanocyte tyrosinase activity with little effect ob-
served on proliferation (Table I). In this study we have investigated 
whether the melanocyte can synthesize IL-1. Using immunocyto-
chemical staining. flow-cytometric analysis. and the PCR tech-
nique. we demonstrated that neonatal and adult human melanocytes 
produce both IL-la and {l (Figs 1-3). Our in lIitro findings on IL-la 
production by melanocytes was confirmed by in lIillo results of im-
munohistochemical staining of human skin that had been grafted 
onto nude mice. In this model for wound healing. it was demon-
strated that melanocytes that stained positively with a specific me-
lanocytic marker also stained positively with anti-IL-1a antibody 
(K. Matsumoto and J. Nordlund. personal communication) . 
The concept of epidermal cell-cell interaction has captured the 
interest of many investigators. It is now well documented tha-t.mel-
anocyte function and proliferation are regulated by a diversity of 
paracri ne factors. such as basic fibroblast growth factor. TNF-a. and 
endothelin-1 [12.15.16]. The results hereby presented. together 
with previously published data from our laboratory. suggest an au-
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tocrine-paracrine role for IL-la and IL-l{l in regulating human 
melanocytes and other epidermal cells. 
The production of immune/inflammatory cytokines is particu-
larl y significant when investigating the response of the epidermis to 
ultraviolet light. It is known that ultraviolet irradiation of epider-
mal cells enhances the synthesis of cytokines [1.17 -20]. The mech-
anisms by which cytokines elicit their effects on human melano-
cytes are unknown. Additionally. the types of cytokine receptors 
expressed on melanocytes and the participation of cytokines in me-
diating the effects of ultraviolet light on melanocytes await to be 
elucidated. 
The melanocytes are basally situated in the epidermis and interact 
with the surrounding keratinocytes via their dendrites. Function-
ally. the melanocyte and keratinocyte work in concert to pigment 
the skin. There is increasing evidence for the involvement of the 
melanocyte in the process of cutaneous inflammation and immunity 
due to its ability to synthesize a variety of immune/i nflammatory 
mediators. We have now established that both neonatal and adult 
human melanocytes produce IL-ta and fl. Because IL-l is a primary 
cytokine that induces many secondary events. the melanocyte may 
also contribute to the initiation of the process of epidermal inflam-
mation [5]. It is also known that ICAM-l expression by melanocytes 
and keratinocytes can be altered by several cytokines and by ultravi-
olet light [10.21-24]. The location of the melanocyte along the 
basement membrane. its ability to synthesize chemotactic factors 
such as leukotriene B4 • and to express ICAM-l suggest a role for this 
cell in leukocyte recruitment and cutaneous inflammation. Future 
studies will be aimed at elucidating the paracrine interactions be-
tween the keratinocyte and melanocyte. and the contribution of the 
melanocyte to the immune function of the epidermis. 
A 
1 2 3 4 5 6 
B 
Figure 3. Expression of IL-1cx and IL-IP - specific mRNA in melanocytes 
as determined by peR. A) IL-tcx expression by melanocytes. Lalles 1-3 
represent an autoradiograph of melanocyte cDNA after amplification with 
labeled p-actin primers (18 cycles). Lalles 4 -6 represent amplifications using 
labeled IL-1 cx primers (27 cycles). Lallf 1 represents the p-actin-positive 
control. Larle 4 represents the IL-lcx - positive control. Lalles 2 and 5 repre-
sent adult melanocytes and fa lies 3 and 6 represent neonatal melanocytes. The 
IL-1a and p-actin amplification products were - 800 base pairs and 1.2 kb. 
respectively. B) IL-IP expression by melanocytes. Lalles 1-3 represent 
an autoradiograph of melanocyte cDNA after amplification with labeled 
p-actin primers (18 cycles). Lalles 4- 6 represent amplifications with labeled 
IL-1P primes (18 cycles). Lallf 1 represents the p-actin-positive control. 
Lallf 4 represents the IL-1P-positive control. Lalles 2 and 5 represent adult 
melanocytes and fall fs 3 and 6 represent neonatal melanocytes. Amplification 
products for IL-1P and p-actin were - 1 kb and - 1.2 kb. respectively. 
Because of the shorter cycle number for IL-1P. B represents a longer expo-
sure time than A. 
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